Award

National Institute of Allergy and Infectious Diseases 5R01AI183970-03

Mechanisms and means to improve HIV bnAb activity in vivo

Recipient

Dartmouth College

Award Amount

$842,637.00

Ceiling

$842,637.00

Awarded

July 29, 2026

Identifier

5R01AI183970-03

This NIH-funded project aims to enhance the efficacy of broadly neutralizing antibodies against HIV by testing strategies to improve their antiviral activity in vivo, including Fc engineering and antibody combinations.

Description

A research grant to define and refine the means by which broadly neutralizing antibodies (bNAbs) can be used to restrict HIV replication in vivo, focusing on improving antiviral activity through Fc engineering and bNAb combinations.

View original record